Search for dissertations about: "Pdx1"
Showing result 1 - 5 of 17 swedish dissertations containing the word Pdx1.
-
1. Embryonic Stem Cells: Differentiation into Insulin Producing Cells and Elimination of Damaged Proteins
Abstract : This thesis includes two different parts: One focusing on how to induce human embryonic stem cells (hESCs) to differentiate into insulin producing cells by following the normal pancreatic development pathway. These cells have then the potential to be an unlimited source for diabetes regenerative medicine. READ MORE
-
2. Pancreatic Endocrine Tumourigenesis : Genes of potential importance
Abstract : Understanding signalling pathways that control pancreatic endocrine tumour (PET) development and proliferation may reveal novel targets for therapeutic intervention. The pathogenesis for sporadic and hereditary PETs, apart from mutations of the MEN1 and VHL tumour suppressor genes, is still elusive. READ MORE
-
3. Mechanisms by which variants in the TCF7L2 gene increase the risk of developing Type 2 diabetes
Abstract : Type 2 diabetes mellitus (T2DM) is a heterogeneous disease with a multifactorial aetiology comprising of genetic and environmental factors. The common variant most highly associated with T2DM known to date is a SNP rs7903146 in the TCF7L2 gene. However, the role TCF7L2 plays in the development of T2DM was unclear. READ MORE
-
4. Functional analysis of Ipf1/Pdx1, MFng and Id during pancreatic growth and differentiation
Abstract : The pancreas is an endodermally derived organ consisting of three major cell lineages. The endocrine cells, organised into the Islets of Langerhans, regulate blood glucose homeostasis by producing and secreting hormones such as glucagon and insulin into the bloodstream. READ MORE
-
5. Non-coding RNAs in beta cell insulin secretion - emerging players in Type 2 Diabetes pathogenesis
Abstract : Type 2 diabetes (T2D) is a complex polygenic disease influenced by both environmental and genetic factors resulting in impaired insulin release from pancreatic beta cells and insulin resistance in target tissues. The incidence of T2D is escalating and it is projected that over 640 million people will be affected by 2040. READ MORE